Advertisements


We are Sorry, This Page doesn't Exist


Nationwide Children"s gene therapy spinoff acquired for $100M

Yet another gene therapy spinoff from Nationwide Children's Hospital has been acquired for $100 million. Celenex is developing a treatment for Batten Disease, a rare, fatal neurological condition that causes blindness and progressive loss of spee.....»»

Category: topSource: bizjournalsSep 21st, 2018

Rumor: Allergan active amid activist investor speculation

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 21st, 2018

Brainstorm Health: Medtronic Buys Mazor, Almirall Allergan Deal, Alcohol Deaths

Brainstorm Health Daily: September 21, 2018 Good morning and happy Friday, readers--This is Sy. We’ve got a jam packed day so we’ll have to keep this one brief, but we’ll be back in the swing of things on Monday. (As a reminde.....»»

Category: europeSource: fortuneSep 21st, 2018

Pfizer granted FDA Breakthrough Therapy designation for 20vPnC

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 20th, 2018

Amicus acquires gene therapy portfolio of ten AAV programs for $100M

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 20th, 2018

Nokia, Altran introduce joint solution to streamline train maintenance

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 20th, 2018

Galectin stock lifts 15% premarket on early cancer combination trial results

Galectin Therapeutics Inc. shares surged 15% in Thursday premarket trade after the company said that combining its therapy, GR-MD-02, with Key.....»»

Category: topSource: marketwatchSep 20th, 2018

Adverum Biotechnologies receives fast track designation for ADVM022 gene therapy

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 19th, 2018

Morgan Stanley: DEA Likely To Reclassify GW Pharma"s Cannabinoid Therapy For US Launch

By Sunday night, the U.S. Drug Enforcement Administration is expected to reclassify GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH)’s Epidiolex to allow medicinal use. This could open the therapy to a new and promising market. read more.....»»

Category: blogSource: benzingaSep 19th, 2018

Here"s why oil could crash in the coming weeks

LM Otero/AP West Texas Intermediate could drop to $65 a barrel later this year as US refinery maintenance season nears, says Tom Kloza from the Oil Price Information Service. Starti.....»»

Category: topSource: businessinsiderSep 18th, 2018

Why WTI Could Crash In The Coming Weeks

Authored by Irina Slav via Oilprice.com, West Texas Intermediate could drop to US$65 a barrel later this year on the back of extra maintenance work at U.S. refine.....»»

Category: blogSource: zerohedgeSep 18th, 2018

Allergan Snaps Up Early Stage Startup, Goes Back To Its Aesthetic Roots

Allergan Snaps Up Early Stage Startup, Goes Back To Its Aesthetic Roots.....»»

Category: topSource: seekingalphaSep 18th, 2018

How to Make a Killing in Gene Therapy

Legendary short-seller Tom Barton now focuses on early-stage biotech investments. He shares his secrets......»»

Category: topSource: barronsSep 18th, 2018

In a bid to appeal to millennials, Botox-maker Allergan is asking them if they"re "bo-curious" (AGN)

Via .....»»

Category: topSource: businessinsiderSep 17th, 2018

Allergan Frown Lines Study Passes Test on Higher Botox Dose

Allergan (AGN) presents positive results from a study, evalu.....»»

Category: worldSource: nytSep 17th, 2018

Allergan price target raised to $218 from $200 at SunTrust

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 17th, 2018

Allergan stock price target raised to $232 from $211 at Raymond James

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchSep 17th, 2018

UPDATE: Mersana Therapeutics stock leaps 4.7% after FDA lifts clinical hold on cancer therapy trial

Mersana Therapeutics Inc. said Monday t.....»»

Category: topSource: marketwatchSep 17th, 2018

Revance downgraded to Market Perform after Allergan data at JMP Securities

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 17th, 2018

Mersana Therapeutics says FDA has lifted partial clinical hold on cancer therapy trial

Mersana Therapeutics Inc. said Monday the U.S. Food an.....»»

Category: topSource: marketwatchSep 17th, 2018